Guidelines for assessing immunocompetency in clinical trials for autoimmune diseases

Clinical trials testing the safety and efficacy of immunosuppressive agents for the treatment of autoimmune diseases should also be designed to evaluate immunocompetency. The most clinically relevant outcome for assessing immunocompetency is the infection rate. Therefore, a systematic approach to sc...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical immunology (Orlando, Fla.). - 1999. - 123(2007), 3 vom: 31. Juni, Seite 235-43
1. Verfasser:	Looney, R John (VerfasserIn)
Weitere Verfasser:	Diamond, Betty, Holers, V Michael, Levesque, Marc C, Moreland, Larry, Nahm, Moon H, St Clair, E William, Autoimmunity Centers of Excellence Immunocompetency Committee
Format:	Aufsatz
Sprache:	English
Veröffentlicht:	2007
Zugriff auf das übergeordnete Werk:	Clinical immunology (Orlando, Fla.)
Schlagworte:	Journal Article Practice Guideline Review Immunosuppressive Agents